Filing Flows › Actinium Pharmaceuticals (ATNM) › Recalls, complaints & regulation
Actinium Pharmaceuticals (ATNM): clinical trials
Actinium Pharmaceuticals (ATNM) beyond its filings: 2 active clinical trials.
Actinium Pharmaceuticals' latest quarter
Actinium Pharmaceuticals, Q2 2026: revenue $35.0M, operating margin 78.8%, net earnings $27.9M, operating cash flow −$5.2M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Actinium Pharmaceuticals have?
2 active studies on ClinicalTrials.gov, 2 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.